malignant brain tumors
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients planed fluorescence guided surgery with 5-ALA
Exclusion criteria
Exclusion criteria: i) the patients with hypersensitivity for 5-ALA ii) the patients with a history of porphyria iii) the patients with severe liver disfunction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The correlation of fluorescence radiance and the malignancy index calculated with the intraoperative rapid measurement of DNA per single cells. | — |
Secondary
| Measure | Time frame |
|---|---|
| Heterogeneity of malignancy calculated with the intraoperative rapid measurement of intracellular amount of DNA in the weak fluorescent area. | — |
Countries
Japan
Contacts
Osaka Medical College Department of Neurosurgery and Endovascular Neurosurgery